UnitedHealth Group Inc. Stock

Equities

UNH

US91324P1021

Managed Healthcare

Market Closed - Nyse 04:00:02 2024-04-19 pm EDT 5-day change 1st Jan Change
501.1 USD +1.61% Intraday chart for UnitedHealth Group Inc. +14.10% -4.81%
Sales 2024 * 399B Sales 2025 * 430B Capitalization 455B
Net income 2024 * 16.71B Net income 2025 * 27.13B EV / Sales 2024 * 1.2 x
Net Debt 2024 * 24.01B Net Debt 2025 * 14.47B EV / Sales 2025 * 1.09 x
P/E ratio 2024 *
27.2 x
P/E ratio 2025 *
16.6 x
Employees 440,000
Yield 2024 *
1.59%
Yield 2025 *
1.77%
Free-Float 99.76%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.61%
1 week+14.10%
Current month+1.30%
1 month+1.58%
3 months-0.48%
6 months-5.74%
Current year-4.81%
More quotes
1 week
441.99
Extreme 441.99
507.30
1 month
436.38
Extreme 436.38
507.30
Current year
436.38
Extreme 436.38
549.00
1 year
436.38
Extreme 436.38
554.70
3 years
383.12
Extreme 383.12
558.10
5 years
187.72
Extreme 187.72
558.10
10 years
74.26
Extreme 74.26
558.10
More quotes
Managers TitleAgeSince
Chief Executive Officer 59 17-08-06
Director of Finance/CFO - 06-10-31
Director of Finance/CFO 61 16-06-06
Members of the board TitleAgeSince
Director/Board Member 67 17-01-12
Director/Board Member 72 06-12-31
Chairman 71 97-05-31
More insiders
Date Price Change Volume
24-04-19 501.1 +1.61% 6,484,260
24-04-18 493.2 +2.96% 8,880,448
24-04-17 479 +2.15% 8,759,779
24-04-16 468.9 +5.22% 11,816,517
24-04-15 445.6 +1.46% 5,376,771

Delayed Quote Nyse, April 19, 2024 at 04:00 pm EDT

More quotes
UnitedHealth Group Inc. is one of the leading American suppliers of healthcare products and services. Income breaks down by activity as follows: - health insurance (57.4%; UnitedHealthcare); - prescription insurance plan management services (39.3%; Optum Health and Optum Rx): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.; - provision of computer services (3.3%; Optum Insight): consulting, development, and integration of solutions for transaction management, healthcare plan management, data processing, etc.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
493.2 USD
Average target price
568.9 USD
Spread / Average Target
+15.35%
Consensus